Percentage of Hemoglobin A1C(HbA1c) as an Indicator of Pre-Diabetic Condition in Impaired Glucose Level Patients
Binay Kumar Raut, Mukesh Kumar Jha, Sapana Koju, Kishor Khanal, Shyam Sundar Malla
Abstract
Binay Kumar Raut, Mukesh Kumar Jha, Sapana Koju, Kishor Khanal, Shyam Sundar Malla
Abstract
Background: The high prevalence of diabetes mellitus has emerged as a worldwide public health problem in the past 20 years. Type 2 diabetes is the most common form of diabetes, estimated to account for 85–90% of diabetes. Hemoglobin A(1c) (HbA1c) has been widely used as a clinically important assessment tool for outcome analyses related to glycemic control. The HbA1c test has been shown to predict the risk for the development of many of the chronic complications in diabetes. Objectives: The study was undertaken to find out if HbA1c levels can be used as indicator of the pre-diabetic condition in patients with impaired blood sugar levels around Kathmandu valley and to find out the percentage of HbA1c in those patients. Also a correlation analysis with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) levels was carried out. Methods: The study was conducted in the Department of Biochemistry, Kathmandu University School of Medical Sciences. A total of 102 patients with impaired blood glucose levels participated in the study. Estimation of HbA1c was performed by using a commercial NycoCard Kit, a rapid in vitro test for the measurement of glycated hemoglobin in human blood. Results: The mean % of HbA1c was found to be 6.44902 amongst the 102 patients and no correlation was found to be observed between HbA1c with IFG and IGT values. Conclusion: In conclusion HbA1c % proved to be a valuable indicator of the pre-diabetic condition and could contribute to understanding the role of the various risk factors of dietary, social and physical nature in the development of diabetes.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: The high prevalence of diabetes mellitus has emerged as a worldwide public health problem in the past 20 years. Type 2 diabetes is the most common form of diabetes, estimated to account for 85–90% of diabetes. Hemoglobin A(1c) (HbA1c) has been widely used as a clinically important assessment tool for outcome analyses related to glycemic control. The HbA1c test has been shown to predict the risk for the development of many of the chronic complications in diabetes. Objectives: The study was undertaken to find out if HbA1c levels can be used as indicator of the pre-diabetic condition in patients with impaired blood sugar levels around Kathmandu valley and to find out the percentage of HbA1c in those patients. Also a correlation analysis with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) levels was carried out. Methods: The study was conducted in the Department of Biochemistry, Kathmandu University School of Medical Sciences. A total of 102 patients with impaired blood glucose levels participated in the study. Estimation of HbA1c was performed by using a commercial NycoCard Kit, a rapid in vitro test for the measurement of glycated hemoglobin in human blood. Results: The mean % of HbA1c was found to be 6.44902 amongst the 102 patients and no correlation was found to be observed between HbA1c with IFG and IGT values. Conclusion: In conclusion HbA1c % proved to be a valuable indicator of the pre-diabetic condition and could contribute to understanding the role of the various risk factors of dietary, social and physical nature in the development of diabetes.
Key concepts: Medicine, Impaired fasting glucose, Diabetes mellitus, Glycated hemoglobin, Glycemic, Impaired glucose tolerance, Internal medicine, Hemoglobin